Boston Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2,898	1,853	1,593	698	1,041
Depreciation & Amortization	1,368	1,269	1,196	1,136	1,093
Loss (Gain) From Sale of Assets	-	-	-	22	-78
Asset Writedown & Restructuring Costs	46	386	58	132	370
Loss (Gain) From Sale of Investments	-139	79	59	1	-250
Stock-Based Compensation	299	266	233	220	194
Other Operating Activities	308	44	134	322	-149
Change in Accounts Receivable	-269	-351	-238	-220	-279
Change in Inventory	-188	-228	-660	-321	-346
Change in Accounts Payable	296	243	118	-255	408
Change in Other Net Operating Assets	-85	-126	10	-209	-134
Operating Cash Flow	4,534	3,435	2,503	1,526	1,870
Operating Cash Flow Growth	31.99%	37.23%	64.02%	-18.40%	24.01%
Capital Expenditures	-876	-790	-711	-588	-554
Sale of Property, Plant & Equipment	-	-	-	12	14
Cash Acquisitions	-1,593	-4,640	-1,811	-1,542	-2,258
Divestitures	-	-	-	5	826
Sale (Purchase) of Intangibles	-	-	-	70	82
Investment in Securities	-254	-280	-89	-24	279
Other Investing Activities	83	23	37	56	14
Investing Cash Flow	-2,640	-5,687	-2,574	-2,011	-1,597
Short-Term Debt Issued	-	187	-	-	-
Long-Term Debt Issued	1,558	2,145	-	3,270	-
Total Debt Issued	1,558	2,332	-	3,270	-
Short-Term Debt Repaid	-1,791	-504	-4	-251	-
Long-Term Debt Repaid	-258	-25	-	-3,184	-
Total Debt Repaid	-2,049	-529	-4	-3,435	-
Net Debt Issued (Repaid)	-491	1,803	-4	-165	-
Issuance of Common Stock	282	230	182	136	110
Preferred Dividends Paid	-	-	-	-55	-55
Dividends Paid	-	-	-	-55	-55
Other Financing Activities	-186	-219	-173	-464	-150
Financing Cash Flow	-395	1,814	5	-548	-95
Foreign Exchange Rate Adjustments	42	-11	-4	-9	-6
Miscellaneous Cash Flow Adjustments	-	-1	-	-	1
Net Cash Flow	1,541	-450	-70	-1,042	173
Free Cash Flow	3,658	2,645	1,792	938	1,316
Free Cash Flow Growth	38.30%	47.60%	91.05%	-28.72%	16.25%
Free Cash Flow Margin	18.22%	15.79%	12.58%	7.40%	11.07%
Free Cash Flow Per Share	2.45	1.78	1.22	0.65	0.92
Cash Interest Paid	319	250	259	450	338
Cash Income Tax Paid	561	656	512	662	302
Levered Free Cash Flow	3,242	1,788	1,850	1,155	2,654
Unlevered Free Cash Flow	3,460	1,978	2,016	1,449	2,867
Change in Working Capital	-246	-462	-770	-1,005	-351

Source: S&P Global Market Intelligence. Standard template. Financial Sources.